New Zealand markets closed

Outset Medical, Inc. (OM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.6100+0.0900 (+2.56%)
At close: 04:00PM EDT
3.6600 +0.05 (+1.39%)
After hours: 05:43PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 186.72M
Enterprise value 162.31M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.45
Price/book (mrq)2.00
Enterprise value/revenue 1.30
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.84
52-week change 3-83.66%
S&P500 52-week change 326.49%
52-week high 324.1300
52-week low 31.9200
50-day moving average 32.5659
200-day moving average 36.0071

Share statistics

Avg vol (3-month) 31.33M
Avg vol (10-day) 32.94M
Shares outstanding 551.72M
Implied shares outstanding 651.72M
Float 850.83M
% held by insiders 11.81%
% held by institutions 199.61%
Shares short (30 Apr 2024) 49.45M
Short ratio (30 Apr 2024) 49.94
Short % of float (30 Apr 2024) 421.42%
Short % of shares outstanding (30 Apr 2024) 418.27%
Shares short (prior month 28 Mar 2024) 48.36M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -134.93%
Operating margin (ttm)-131.04%

Management effectiveness

Return on assets (ttm)-28.78%
Return on equity (ttm)-109.07%

Income statement

Revenue (ttm)125.08M
Revenue per share (ttm)2.50
Quarterly revenue growth (yoy)-15.80%
Gross profit (ttm)N/A
EBITDA -157.31M
Net income avi to common (ttm)-168.77M
Diluted EPS (ttm)-3.3600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)226.92M
Total cash per share (mrq)4.39
Total debt (mrq)202.51M
Total debt/equity (mrq)217.28%
Current ratio (mrq)6.42
Book value per share (mrq)1.80

Cash flow statement

Operating cash flow (ttm)-132.53M
Levered free cash flow (ttm)-74.9M